AssetMark Inc
VKTX icon

AssetMark Inc’s Viking Therapeutics VKTX Stock Holding History

AssetMark Inc’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$126K Buy
3,870
+462
+14% +$14.8K ﹤0.01% 1467
2025
Q4 		$120K Sell
3,408
-8,989
-73% -$319K ﹤0.01% 1436
2025
Q3 		$326K Sell
12,397
-520
-4% -$15.5K ﹤0.01% 1165
2025
Q2 		$342K Buy
12,917
+2
+0% +$53 ﹤0.01% 1109
2025
Q1 		$312K Buy
12,915
+789
+7% +$24.9K ﹤0.01% 1063
2024
Q4 		$488K Buy
12,126
+1,637
+16% +$93.3K ﹤0.01% 961
2024
Q3 		$664K Buy
10,489
+9,198
+712% +$540K ﹤0.01% 851
2024
Q2 		$68.4K Buy
1,291
+528
+69% +$34.6K ﹤0.01% 1174
2024
Q1 		$62.6K Buy
+763
New +$34K ﹤0.01% 1123

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return